Skip to content

Combination of acupuncture and traditional Chinese medicine to improve the sciatica of lumbar disc herniation: a randomized controlled trial

Combination of acupuncture and traditional Chinese medicine to improve the sciatica of lumbar disc herniation: a randomized controlled trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070884
Enrollment
Unknown
Registered
2023-04-25
Start date
2023-04-12
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sciatica of lumbar disc herniation

Interventions

Testing group:Shenxie Zhitong capsule + Acupuncture treatment (Yaojiaji, Yaotu, Huantiao and Weizhong)

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 18 – 75 years old 2. Unilateral, single L5 or S1 radiculopathy (leg pain following dermatomal distribution) a. Leg dominant pain b. Positive straight leg raise <70 degrees 3. MRI with corresponding L4-5 or L5-S1 posterolateral disc herniation 4. VAS score for leg pain intensity 4-7 (0-10:0 = no pain, 10 worst pain) 5. Radicular symptom duration greater than 3 months <12 months. 6. Participate voluntarily in this trial and sign the "Informed Consent Form".

Exclusion criteria

Exclusion criteria: 1. Radiculopathy secondary to foraminal stenosis 2. Radiculopathy secondary to intra-foraminal or far lateral disc herniation 3. Radiculopathy secondary to lumbar central or lateral recess stenosis 4. Previous lumbar surgery at the involved level 5. Received other non-traditional Chinese medicine acupuncture conservative treatment within 2 weeks. 6. Received NSAID treatment within 2 weeks. 7. Lumbar spondylolisthesis or lateral listhesis at level of disc herniation 8. Previous epidural/SNR block at involved level 9. Medical contra-indication (i.e cancer) 10. Pregnancy and lactating patients. 11. History of severe cardiovascular and cerebrovascular diseases, renal insufficiency or undergoing cardiovascular disease intervention (surgery or drugs). 12. History of allergy to this study medication intervention. 13. Lack of permanent home address 14. Drug Abuse 15. Using antidepressants. 16. Alcohol Abuse 17. Inability to comprehend questionnaires or provide study consent

Design outcomes

Primary

MeasureTime frame
visual analogue scale for intensity of sciatica(0-10: 0 = no pain, 10 worst pain);

Secondary

MeasureTime frame
VAS for leg pain intensity (0-10: 0 = no pain, 10 worst pain);VAS for central back pain intensity (0-10: 0 = no pain, 10 worst pain);VAS for leg pain frequency (0-10: 0= never, 10 constant);VAS for central back pain frequency(0-10: 0 = no pain, 10 worst pain);Oswestry Disability Index (function specific outcome measure);SF-36 (Generic health outcome measure);Return to Work Status;Satisfaction;

Countries

China

Contacts

Public ContactShi Ying

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

shiying1974@126.com+86 13621612201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026